Rebleeding · people with subarachnoid haemorrhage from a ruptured intracranial aneurysm
Endovascular coiling may leads to higher rebleeding postprocedure up to 10 years compared with neurosurgical clipping (low certainty).
1 finding from 1 review
Activity · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes activity: intermediate term (1 to 5 years compared with microfracture (very low certainty).
1 finding from 1 review
Activity: long term (5 or more years · Adults with isolated cartilage defects (defect areas 1.0 cm2 to 6.0 cm2) of the knee
It is very uncertain whether mosaicplasty changes activity: long term (5 or more years compared with microfracture (very low certainty).
1 finding from 1 review
Change in sensory score after two years · patients with nerve damage in leprosy
1 finding from 1 review
Change in motor score after two years · patients with nerve damage in leprosy
1 finding from 1 review
Mortality among children less than 5 years Verbal autopsy · patients with reducing mortality and morbidity in children <5 years
LHWs showed no clear difference in mortality among children less than 5 years Verbal autopsy compared with usual care (low certainty).
1 finding from 1 review
BMI short‐term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 5 to 11 years
2 findings from 1 review
zBMI short term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 5 to 11 years
1 finding from 1 review
zBMI long term (> 15 months) · children aged 5 to 11 years
1 finding from 1 review
Serious adverse events · children aged 5 to 11 years
1 finding from 1 review
BMI short‐term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 5 to 11 years
2 findings from 1 review
zBMI short term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review
zBMI medium term (9 months to < 15 months) · children aged 5 to 11 years
1 finding from 1 review
Body‐mass index (BMI) · children aged 5 to 11 years
2 findings from 1 review
zBMI long term (> 15 months) · children aged 5 to 11 years
1 finding from 1 review
Serious adverse events · children aged 5 to 11 years
1 finding from 1 review
zBMI short term (12 weeks from baseline to < 9 months) · children aged 5 to 11 years
1 finding from 1 review